Fat Loss Weight Loss 

Weight Loss Peruvian Recipe

Product Name: Weight Loss Peruvian Recipe Click here to get Weight Loss Peruvian Recipe at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Weight Loss Peruvian Recipe is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will…

Read More
Fat Loss Weight Loss 

The Weight Loss Motivation Bible: How To Program Your Mind For Sustainable Fat Loss

Product Name: The Weight Loss Motivation Bible: How To Program Your Mind For Sustainable Fat Loss Click here to get The Weight Loss Motivation Bible: How To Program Your Mind For Sustainable Fat Loss at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. The Weight Loss Motivation Bible: How To Program Your Mind For Sustainable Fat Loss is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60…

Read More
Fat Loss 

his drink is 100% natural and it cleans our arteries from toxins, chemicals and …

his drink is 100% natural and it cleans our arteries from toxins, chemicals and fats that could do us harm. Source by pdm1995leafs67

Read More
Fat Loss 

NEGDA: Supports immune, heart, breast, prostate, colon and pancreas overall health, fights against cell-damaging totally free radicals, defends the body against oxidation harm. (30 Vegetarian Capsules – Males) | Weight Loss

NEGDA: Supports immune, heart, breast, prostate, colon and pancreas overall health, fights against cell-damaging totally free radicals, defends the body against oxidation harm. (30 Vegetarian Capsules – Males) – www.qualitylosswe… Source by drjanet123

Read More

FDA Approves Implant to Battle Opioid Addiction

www.judgeweightloss.com/bikinibutt

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Dennis Thompson
HealthDay Reporter

THURSDAY, May 26, 2016 (HealthDay News) — A new long-acting implant that can help treat people addicted to heroin and prescription painkillers was approved Thursday by the U.S. Food and Drug Administration.

“Opioid abuse and addiction have taken a devastating toll on American families. We must do everything we can to make new, innovative treatment options available that can help patients regain control over their lives,” FDA Commissioner Dr. Robert M. Califf said in a statement. “Today’s approval provides the first-ever implantable option to support patients’ efforts to maintain treatment as part of their overall recovery program.”

Probuphine is placed in the upper arm of recovering addicts and releases a steady six-month dose of buprenorphine, an anti-addiction drug designed to combat the cravings that come with opioids like heroin or powerful prescription painkillers like Percocet or OxyContin. Buprenorphine is already available as a pill or a film that can be placed in the mouth.

The steady flow from the implant will reduce fluctuations that can occur when taking a medication once or twice daily, and it removes the need for a patient to remember to take it, said Dr. Annie Umbricht, an expert in substance abuse treatment at Johns Hopkins University in Baltimore.

“A person suffering from addiction would not have to go through the up-and-downs of a daily medication, and therefore will feel much more normal,” Umbricht explained.

Clinical trials published in the Journal of the American Medical Association in 2010 showed the implant led to higher abstinence rates among addicts, with 40 percent remaining drug-free compared with 28 percent receiving a placebo.

People given the implant also were more likely to remain in treatment, about 66 percent compared with 31 percent of the placebo group.

“It really reduces or eliminates cravings, and they don’t start searching around for opiates,” said Dr. Scott Segal, president and chief medical officer of the Segal Institute for Clinical Research in Miami, one of the centers that participated in the clinical trials.

The implant provides patients with no-fail treatment during its six-month period of effectiveness, Segal said.

“Things happen in life,” he said. “You miss your doctor’s appointment, the pharmacy doesn’t have the medication and there’s problems. The implant takes relapse off the table.”

It takes about 15 minutes to place the implant, Segal said, and side effects are similar to oral buprenorphine. They include headache, depression, constipation, nausea, vomiting and back pain, according to the FDA.

“I was concerned that patients would [not] like this option, and I was dead wrong,” he said. “The patients enrolled quickly. They liked it. They tolerated it well. And they were upset when we took them off the implant at the end of the study.”

The United States is experiencing an epidemic of prescription drug abuse, and the new implant could also help counter that, Umbricht said.

There were 28,647 overdose deaths related to heroin and prescription pain killers in 2014, an average of 78 per day, according to the U.S. Centers for Disease Control and Prevention.

That’s because people undergo treatment and lose their tolerance for opioids, but then leave treatment with a high risk of relapse, Umbricht said.

“We know the rate of relapse after drug treatment is more than 90 percent,” Umbricht said. “These people have lost their tolerance, but they don’t realize it. They are at high risk for overdose.”

The implant can help stabilize addicts during treatment, and then provide them with support against relapse once they’ve been released, she said.

Buprenorphine provides effects that are similar to, but weaker than, opioids like heroin or methadone, according to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).

But those effects level off at moderate doses, lowering the risk of misuse and addiction, SAMHSA says.

Buprenorphine also interferes with the effects of full-strength opiates, Segal said.

“It tends to saturate the receptors that respond to opiates,” he said. “Even if you were to take opiates with it, you won’t get high. It provides pain relief, but doesn’t give them the buzz or high that heroin would.”

The implant eliminates one other concern associated with oral buprenorphine—the likelihood that someone with a prescription will share their pills with friends.

Researchers estimate that as much as 50 percent of oral buprenorphine prescriptions are “diverted,” Umbricht said.

The intent is most likely to help other people quit their drug habit, Umbricht said, but without drug counseling those addicts are not likely to succeed.

“That person is not going to get the psychosocial support they need,” Umbricht said, adding that drug sharing also maintains illegal behaviors that recovering addicts need to shake.

Addiction specialist Dr. Kevin Cotterell agreed.

“The prospect of a long-acting opiate agonist-antagonist surgically implanted for use in the treatment of addiction to opiates is very encouraging,” said Cotterell, a psychiatrist with South Oaks Hospital in Amityville, N.Y. “It will help in overcoming problems with compliance, which is a great barrier to recovery. It will enhance safety and reduce diversion if used widely.”

More information

For more on buprenophine, visit the Substance Abuse and Mental Health Services Administration.


Also check out healthywithjodi.com

Read More

FDA Approves Implant to Battle Opioid Addiction

www.judgeweightloss.com

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Dennis Thompson
HealthDay Reporter

THURSDAY, May 26, 2016 (HealthDay News) — A new long-acting implant that can help treat people addicted to heroin and prescription painkillers was approved Thursday by the U.S. Food and Drug Administration.

“Opioid abuse and addiction have taken a devastating toll on American families. We must do everything we can to make new, innovative treatment options available that can help patients regain control over their lives,” FDA Commissioner Dr. Robert M. Califf said in a statement. “Today’s approval provides the first-ever implantable option to support patients’ efforts to maintain treatment as part of their overall recovery program.”

Probuphine is placed in the upper arm of recovering addicts and releases a steady six-month dose of buprenorphine, an anti-addiction drug designed to combat the cravings that come with opioids like heroin or powerful prescription painkillers like Percocet or OxyContin. Buprenorphine is already available as a pill or a film that can be placed in the mouth.

The steady flow from the implant will reduce fluctuations that can occur when taking a medication once or twice daily, and it removes the need for a patient to remember to take it, said Dr. Annie Umbricht, an expert in substance abuse treatment at Johns Hopkins University in Baltimore.

“A person suffering from addiction would not have to go through the up-and-downs of a daily medication, and therefore will feel much more normal,” Umbricht explained.

Clinical trials published in the Journal of the American Medical Association in 2010 showed the implant led to higher abstinence rates among addicts, with 40 percent remaining drug-free compared with 28 percent receiving a placebo.

People given the implant also were more likely to remain in treatment, about 66 percent compared with 31 percent of the placebo group.

“It really reduces or eliminates cravings, and they don’t start searching around for opiates,” said Dr. Scott Segal, president and chief medical officer of the Segal Institute for Clinical Research in Miami, one of the centers that participated in the clinical trials.

The implant provides patients with no-fail treatment during its six-month period of effectiveness, Segal said.

“Things happen in life,” he said. “You miss your doctor’s appointment, the pharmacy doesn’t have the medication and there’s problems. The implant takes relapse off the table.”

It takes about 15 minutes to place the implant, Segal said, and side effects are similar to oral buprenorphine. They include headache, depression, constipation, nausea, vomiting and back pain, according to the FDA.

“I was concerned that patients would [not] like this option, and I was dead wrong,” he said. “The patients enrolled quickly. They liked it. They tolerated it well. And they were upset when we took them off the implant at the end of the study.”

The United States is experiencing an epidemic of prescription drug abuse, and the new implant could also help counter that, Umbricht said.

There were 28,647 overdose deaths related to heroin and prescription pain killers in 2014, an average of 78 per day, according to the U.S. Centers for Disease Control and Prevention.

That’s because people undergo treatment and lose their tolerance for opioids, but then leave treatment with a high risk of relapse, Umbricht said.

“We know the rate of relapse after drug treatment is more than 90 percent,” Umbricht said. “These people have lost their tolerance, but they don’t realize it. They are at high risk for overdose.”

The implant can help stabilize addicts during treatment, and then provide them with support against relapse once they’ve been released, she said.

Buprenorphine provides effects that are similar to, but weaker than, opioids like heroin or methadone, according to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).

But those effects level off at moderate doses, lowering the risk of misuse and addiction, SAMHSA says.

Buprenorphine also interferes with the effects of full-strength opiates, Segal said.

“It tends to saturate the receptors that respond to opiates,” he said. “Even if you were to take opiates with it, you won’t get high. It provides pain relief, but doesn’t give them the buzz or high that heroin would.”

The implant eliminates one other concern associated with oral buprenorphine—the likelihood that someone with a prescription will share their pills with friends.

Researchers estimate that as much as 50 percent of oral buprenorphine prescriptions are “diverted,” Umbricht said.

The intent is most likely to help other people quit their drug habit, Umbricht said, but without drug counseling those addicts are not likely to succeed.

“That person is not going to get the psychosocial support they need,” Umbricht said, adding that drug sharing also maintains illegal behaviors that recovering addicts need to shake.

Addiction specialist Dr. Kevin Cotterell agreed.

“The prospect of a long-acting opiate agonist-antagonist surgically implanted for use in the treatment of addiction to opiates is very encouraging,” said Cotterell, a psychiatrist with South Oaks Hospital in Amityville, N.Y. “It will help in overcoming problems with compliance, which is a great barrier to recovery. It will enhance safety and reduce diversion if used widely.”

More information

For more on buprenophine, visit the Substance Abuse and Mental Health Services Administration.


Also check out healthywithjodi.com

Read More

13 Things You Need to Know About the Zika Virus

www.judgeweightloss.com

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Dennis Thompson
HealthDay Reporter

What is Zika?

Zika is a virus first discovered in 1947 and named after the Zika forest in Uganda. The first human cases of Zika were detected in 1952, but until last year there had been only isolated outbreaks occurring mainly in tropical locales.

How is it transmitted?

Zika is spread primarily through the bite of an infected Aedes aegypti or Aedes albopictus mosquito. Mosquitoes become infected by drinking the blood of a person infected with Zika, and then spread the disease to other people.

A man infected with Zika can transmit the virus through sexual intercourse. Also, people can be infected if they are given a blood transfusion tainted with Zika.

Who faces the greatest health risk from Zika?

Four out of five people infected with Zika do not develop any symptoms. Those who do most often suffer from mild symptoms that include fever, rash, joint pain, or red eyes.

The true risk of Zika is to a developing fetus. The U.S. Centers for Disease Control and Prevention has confirmed that Zika can cause terrible birth defects if a pregnant woman is infected with the virus.

What kind of birth defects does Zika cause?

Microcephaly is the most common birth defect caused by Zika, and it involves abnormally small development of the head and brain. Zika also causes other brain-related birth defects, and can result in miscarriage, according to the CDC.

What are the chances Zika exposure during pregnancy will cause microcephaly?

Not every fetus exposed to Zika develops a birth defect. Women infected with Zika have given birth to apparently healthy babies, although health experts can’t guarantee that these babies won’t develop problems later in life. No one knows what the odds are that a birth defect will occur. This is one of the CDC’s ongoing areas of research.

What can a woman who’s pregnant or trying to get pregnant do to protect herself?

Women of child-bearing age who live in an active Zika region should protect themselves from mosquito bites by wearing long-sleeved shirts and long pants, using mosquito repellent when outside, and staying indoors as much as possible.

Women should use condoms or refrain from sex with a male partner if they are living in an active Zika area. They also should follow these precautions for at least 8 weeks if the man has traveled to an active Zika area, or for at least 6 months if the man has been diagnosed with Zika.

What can be done if a pregnant woman is infected with Zika?

There is no cure or vaccine for Zika. Pregnant women infected with Zika will be monitored by doctors, who will closely track fetal development.

Will a Zika infection threaten all future pregnancies?

The CDC has said there’s no evidence that a past Zika virus infection will endanger future pregnancies. It appears that once the virus has been cleared from a person’s bloodstream, it poses no risk to any subsequent pregnancies.

What other illnesses can Zika cause?

Zika has been associated with Guillain-Barre syndrome (GBS), a rare disease of the nervous system in which a person’s immune system attacks nerve cells. The disease causes muscle weakness and, less frequently, paralysis. Most people recover fully, but some have permanent damage and about one in 20 die.

CDC Director Dr. Tom Frieden has said it is very likely that Zika causes GBS, given that the syndrome also is triggered by a number of different bacterial or viral infections. However, the link has not been confirmed. The CDC is investigating.

Where in the U.S. is Zika likely to become active?

Zika already is active in the territory of Puerto Rico, where one death has been reported, as well as American Samoa and the U.S. Virgin Islands. Public health officials expect Zika to strike first in the continental United States in Florida, Louisiana or Texas, once the mosquito season gets underway. The A. aegypti mosquito can range as far north as San Francisco, Kansas City and New York City, although health officials have said infections that far north are unlikely.

What can I do to reduce the risk of Zika becoming active in my neighborhood?

People can help reduce their area’s risk by eliminating mosquito habitats from their property. Get rid of any source of standing water, such as buckets, plastic covers, toys or old tires. Empty and change the water in bird baths, fountains, wading pools and potted plants once a week. Drain or fill with dirt any temporary pools of water, and keep swimming pool water treated and circulating, according to the CDC.

Report any mosquito activity in your neighborhood to your local mosquito control program.

What should I do if I think I’ve been exposed to Zika?

The CDC recommends that people contact their health care provider if they are suffering from Zika-like symptoms, particularly if they are pregnant. Tests are available that can confirm Zika infection.

Is there a vaccine for Zika?

No, but the CDC is working with pharmaceutical companies to ramp up research into a vaccine for the virus.


Also check out healthywithjodi.com

Read More

Here's How Much You Need to Exercise If You Sit at a Desk All Day, According to Science

www.popsugar.com/fitness/Exercise-Formula-Counteract-Sitting-42113170

Thank You for visiting www.judgeweightloss.com. This is the spot for all of your fitness, workout, healthy lifestyle, supplement, and just general get healthy information. Enjoy

The perils of sitting all day aren’t good. Researchers have shown that remaining stationary for extended periods of time (like at your 9-to-5 desk job) can be detrimental to your health. While exercise is a big part of offsetting the harmful effects of sitting, it was unclear how many gym sessions were needed to help — until now.

A new study, published in The Lancet, shows the ideal formula for counteracting the negative effects of a sedentary job. Instead of a fixed number of hours spent exercising, the ratio depends on how much you sit: people who work a typical eight-hour day should spend at least one hour each day moving; if you sit six hours a day, you should spend half an hour exercising. The research also indicated that the exercise doesn’t have to be all at once — or rigorous. It can be spread throughout the day and be as simple as walking.

20330826

The team behind the study analyzed data from a pool of a million adults over the age of 45 in Western Europe, the United States, and Australia. Using previous data, the researchers examined data from 16 published studies and used it to determine how much exercise is required to compensate for sitting. Their recommended daily exercise goal is higher than previous advice but not necessarily less attainable, given it can be completed throughout the day.

Fitting in an hour of exercise a day sounds especially daunting if you have a desk job, but there are plenty of workouts you can complete before and after work. Even if it means taking a 10-minute walk during lunch, your body will thank you in the long run.

Read More

There's a Lump in My Armpit—Should I Be Worried?

www.judgeweightloss.com

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

Q: There’s a painful lump in my armpit. What could it be?

Does it look red and inflamed or filled with pus? If so, it may just be an ingrown hair or infected follicle from shaving or using antiperspirant. Avoid shaving and applying product there, clean the area gently with soap in the shower, and apply warm compresses several times a day for a few days, and it should clear up.

RELATED: Viral Photo Is a Reminder That Lumps Aren’t the Only Breast Cancer Symptom to Look Out For

Another possibility: You have a lipoma, which is a knot of fatty tissue that commonly grows in places like the shoulders, neck, and armpits. While you can get them at any age, they mostly form in adults between 40 and 60. They’re almost always harmless and painless. However, one may cause pain if it lies on any nerves. If it bothers you, your doctor can remove it, typically by making a small incision and taking out the tissue.

Or you could have a swollen lymph node. Predominantly located in the neck, groin, and underarm areas, lymph nodes act as filters to trap “intruders” in your body (think germs and cancer cells). They can become painful and enlarged when you have an infection, like strep throat or mononucleosis. The swelling and discomfort usually go away when the infection does. Some women also have small amounts of breast tissue near the armpit, so if you notice soreness just before your period, it may be due to the same hormonal changes that cause period-related breast tenderness.

RELATED: You Found a Lump In Your Breast. Now What?

If the lump doesn’t disappear in a couple of weeks or gets bigger, or if the pain seems to worsen, it could be a cyst, a breast infection or (very rarely) a tumor. See your doctor to get it checked out.

Health’s medical editor, Roshini Rajapaksa, MD, is assistant professor of medicine at the NYU School of Medicine.

Also check out healthywithjodi.com

Read More